Germany’s Merck in advanced talks to acquire US biotech firm Springworks

11 February 2025, 12:49 pm

1 min read

FILE PHOTO: FILE PHOTO: A logo of drugs and chemicals group Merck KGaA is pictured in Darmstadt, Germany January 28, 2016. REUTERS/Ralph Orlowski/File Photo

Reuters broke the news that Merck, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases drugmaker Springworks Therapeutics. Springworks’ shares jumped nearly 49% on the Reuters story to touch its highest level since April 2022. Merck later released a statement confirming the Reuters scoop.